Clinical Trial Update: Short-term Outcomes of SILS+1 Versus CLS for Distal Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing SILS+1 versus CLS for distal gastric cancer; short-term outcomes reported, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Gastric Cancer

Drugs mentioned

• CLS
• SILS+1

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Surgery | Phase 3 | Status: UNKNOWN